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Our understanding of themodulation of proteins has shifted in direction with the discovery
of microRNAs (miRs) over twenty years ago. MiRs are now in the “limelight” as these
non-coding pieces of RNA (generally ∼22 nucleotides long) result in altered translation
and function of proteins. Indeed, miRs are now reported to be potential biomarkers of
disease. Epithelial K+ channels play many roles in electrolyte and fluid homeostasis of the
human body and have been suggested to be therapeutic targets of disease. Interestingly,
the role of miRs in modulating K+ channels of epithelial tissues is only emerging now.
This minireview focuses on recent novel findings into the role of miRs in the regulation of
K+ channels of epithelia.
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INTRODUCTION
Epithelial K+ channels perform numerous physiological roles in K+ homeostasis of the body.
K+ channels participate in maintenance of cellular membrane potential, secretion of ions and
fluid, maintenance of blood pressure, cell proliferation, and renal fibrosis (Balut et al., 2012).
Indeed, many epithelia K+ channels contribute to disease; therefore, it is not surprising that
K+ channels have been identified as potential therapeutic targets (Wulff et al., 2009; Wulff and
Köhler, 2013). MicroRNAs are gaining importance as therapeutic targets for disease (Tutar et al.,
2015). Surprisingly, there is a significant gap in our knowledge of the role of miRs in modulating
epithelial K+ channels. This minireview focuses on recent novel findings into the role of miRs in
the regulation of K+ channels of epithelia.
FORMATION OF miRNAs
MiRs are short non-coding pieces of RNA, which are∼22 nucleotides long. Ambros and colleagues
(Lee et al., 1993) described the first miR identified in Caenorhabditis elegans when they isolated
the lin-4 gene. They reported that lin-4 did not code for a protein, instead it produced a short
non-coding piece of RNA which contained semi-complimentary sequences to multiple areas in the
3′-untranslated region (UTR) of lin-14 mRNA (Lee et al., 1993). Indeed, Ambros and co-workers
suggested that lin-4 regulated the translation of the Lin-14 protein by an antisense RNA-RNA
interaction. As of this writing, the microRNA database lists >28,600 loci of miRNAs (Kozomara
and Griffiths-Jones, 2014; http://www.mirbase.org/).
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MiRs are transcribed in the nucleus of cells from DNA. The
enzyme RNA polymerase II (RNase II) transcribes DNA into a
primary RNA (pri-miRNA) within the nucleus. The pri-miRNA
is recognized by the nuclear protein DiGeorge syndrome critical
region 8 (DGCR8) that associates with Drosha, a RNase III, which
cleaves the pri-miRNA generating a precursor miR-RNA (pre-
miRNA) (Figure 1). The pre-miRNA then exits the nucleus via
a nuclear pore with the assistance of Exportin 5 (Yi et al., 2003).
Finally, the pre-miRNA is cleaved by the enzyme Dicer, resulting
in the mature miRNA (Figure 1) (Filipowicz et al., 2005).
Mature miRNAs bind to the 3′UTR of mRNA to repress gene
expression (Filipowicz et al., 2005), however, modulation of some
miRs results in altered protein upregulation (Bhattacharyya et al.,
2006). It is apparent, that miRs have differing effects, depending
on how they bind to their target mRNA. If the miR sequence is
perfectly complimentary (Figure 1), then the miR will lead to the
degradation of the mRNA (Jing et al., 2005). However, if the miR
sequence is only partially complimentary to its target mRNA,
only part of the miR will bind to the mRNA, resulting in blocked
protein formation (Lim et al., 2005).
MiR-802 AND MiR-194 INCREASE KIR1.1
(KCNJ1) ABUNDANCE IN THE KIDNEY BY
INDIRECT PATHWAYS
In the cortical collecting duct (CCD), KIR1.1 aids in regulating
the amount of K+ in the body by selectively secreting K+ into
the urine (Welling and Ho, 2009). Indeed, the modulation and
distribution of KIR1.1 in the plasma membrane is altered by
dietary K+ intake (Wang, 2004). Recent studies have established
that miRs participate in the regulation of KIR1.1, and are also, in
part regulated by K+ intake (Lin et al., 2011, 2014).
miR-802 AND KIR1.1
Wang and colleagues (Lin et al., 2011) provided the first evidence
that mirR-802 regulated membrane expression and activity
FIGURE 1 | Transcription of miRNA from DNA. Pri-miRNA is transcribed
from DNA by the enzyme RNA polymerase II. The pri-miRNA is recognized by
DGCR8 that associates with Drosha which cleaves the pri-miRNA to form a
pre-miRNA, The pre-miRNA exits the nucleus via exportin 5. Finally, the
pre-miRNA is cleaved by Dicer into mature miRNA. The mature miRNA can then
bind either perfectly or imperfectly to its target mRNA. DGCR8, DiGeorge
syndrome critical region 8.
of KIR1.1 by modulating caveolin-1 (Figure 2A). Initially, the
authors performed a miR microarray assay on mouse kidney of
animals fed a high K+ diet to identify potential miRs that might
modulate KIR1.1. One miR identified was miR-802. The authors
used multiple approaches to determine the role of miR-802 in the
regulation of KIR1.1. Using Northern blot and PCR experiments,
they demonstrated that miR-802 was elevated in the kidney of
mice fed a high K+ diet. Additionally, using qRT-PCR, they
reported increased levels of pre-miR-802 in CCDs isolated from
mice fed a high K+ diet. Therefore, Lin et al. (2011) established
that miR-802 was present in the mouse CCDs and the miR was
modulated by high K+ diet.
After which, Lin et al. (2011), used databases and identified
that the 3′UTR of caveolin-1 contained a recognized binding
site for miR-802. Caveolin-1 is a scaffolding protein located
in the plasma membrane of most cells (Li et al., 1996;
Schubert et al., 2002). The authors used human embryonic
kidney (HEK) cell line, a caveolin-1 mutant 3′UTR and a
microRNA-sponge (to “absorb” the mature form of miR-802)
approach. They demonstrated that miR-802 modulated the
3′UTR of caveolin-1 (luciferase activity) and the miR-802
“sponge” increased the expression of endogenous cavelolin-
1 (immunoblot), providing evidence that miR-802 reduced
expression of caveolin-1. Since miR-802 regulated the expression
of caveolin-1, they hypothesized that a high K+ diet would
result in reduced caveolin-1 expression. Indeed, they provided
conclusive immunoblot evidence that caveolin-1, but not
caveolin-2, was reduced in both the kidney of the mice and rats
fed a high K+ diet.
Thereafter, Lin et al. (2011) turned their efforts to linking
miR-802 and caveolin-1 in the regulation of KIR1.1. Initially,
they asked whether caveolin-1 and KIR1.1 were closely associated
in a microdomain. They used a detergent-free purification
technique to extract caveolin-1 and KIR1.1 from the mouse
kidney and analyzed extracts in a parallel centrifugation
continuous sucrose gradient. They demonstrated that
KIR1.1 was located in caveolin-1 rich fractions suggesting
caveolin-1 and KIR1.1 were physically close. Second, they
identified three presumed caveolin-1 binding motifs in
the N-terminus of KIR1.1, after which, they demonstrated,
in HEK cells by immunoblot, that transfected KIR1.1 was
co-immunoprecipitated with endogenous caveolin-1, and
that caveolin-1 was co-immunoprecipitated with the KIR1.1
N-terminus.
As mentioned above, caveolin-1 is a scaffolding protein that
regulates endocytosis and exocytosis of surface proteins (Wyse
et al., 2003; González et al., 2007). Lin et al. (2011) asked whether
caveolin-1 regulated the surface expression of KIR1.1. They used
a surface biotin-labeling technique with M-1 cells (CCD cell line,
Stoos et al., 1991) that were transfected with GFP- KIR1.1 to
examine the effect of caveolin-1 on KIR1.1 expression. After 48 h,
they demonstrated caveolin-1 reduced the surface expression
of KIR1.1 as measured by immunoblot. Subsequently, reducing
endogenous caveolin-1 with siRNA resulted in increased
expression of KIR1.1 at the plasma membrane. These data clearly
demonstrated that caveolin-1 regulated the expression of KIR1.1
in M-1 cells. Further, to determine if the expression of caveolin-
1 reduced the amount of KIR1.1 at the membrane, the authors
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FIGURE 2 | The actions of miRs on epithelial K+ channels. (A) The action of miR-194 and miR-802 on upregulation of KIR1.1. Upper Panel: MiR-194 inhibits
Intersectin 1, which mitigates the inhibition of KIR1.1 by intersectin 1 and increases KIR1.1. Lower Panel: miR-802 inhibits caveolin 1 which relieves the inhibition of
KIR1.1 by caveolin 1 and increases KIR1.1. (B) The action of miR-205 on KIR4.1 in a native human corneal epithelial cells (HCECs) it to suppress KIR4.1 causing the
cells to depolarize, which activates voltage-gated Ca2+ channels in HCECs, thus, increasing the healing process. (C) The action of miR-204 on KIR7.1 in retinal
pigment epithelium. The effect of miR-204 on the increased expression of KIR7.1 was caused by miR-204’s suppressing action on TGF-βR2, through an unknown
mechanism, followed by reduced signaling of protein kinase C which resulted in increased expression of KIR7.1. (D) MiR-7 regulates the expression of KIR2.1 in
small-cell lung cancer cells (SCLCs). When miR-7 levels was elevated, the mRNA for KIR2.1 was reduced which reduced the expression of KIR2.1 at the membrane.
There was a inverse correlation between MiR-7 expression levels and the expression of KIR2.1 and multi-drug resitance protein 1 which resulted in increased
chemosenetivity to SCLCs.
provided functional data, with patch-clamp experiments, that co-
expression of caveolin-1 and KIR1.1 caused a large decrease in
K+ current when compared to K+ current of cells not transfected
with caveolin-1. Finally, with a combination of perforated whole
cell experiments with HEK cells, Lin et al. (2011) reported that
co-transfection of KIR1.1 and pre-miR-802 or KIR1.1 + pre-
miR-802 + caveolin-1 for 24 h resulted in that (i) pre-miR-802
increased K+ currents of KIR1.1, (ii) the effect of miR-802 on
K+ currents was due to decreased expression of caveolin-1, since
expression of mutant caveolin-1 (missing 3′UTR) reduced the
effect of pre-miR-802 and decreased the K+ currents, and (iii)
in M1-cells, miR-802 stimulated the surface expression of KIR1.1.
Therefore, miR-802 increased the surface expression of KIR1.1,
by reducing caveolin-1 that increased the activity of KIR1.1
(Figure 2A).
miR-194 AND KIR1.1
MiR-194 is present in kidney (Tian et al., 2008). As with miR-802,
Wang and coworkers (Lin et al., 2014) used a similar high K+ diet
experimental approach to investigate the role of miR-194 in the
regulation of KIR1.1 by targeting intersectin 1 (ITSN1). ITSN1 is a
cytoplasmic membrane-associated protein that aids in trafficking
of endosomes (Yamabhai et al., 1998; Okamoto et al., 1999).
Wang and colleagues (Lin et al., 2014) demonstrated the
up regulation of miR-194 in the mouse kidney of animals fed
a high K+ diet as determined by Northern blot. Next, they
demonstrated, by qRT-PCR, that miR-194 was increased in the
CCDs of mice that were fed a high K+ diet. The authors then,
identified, through database analysis, that the 3′UTR of ITSN1
contained a putative binding site for miR-194. Therefore, they
hypothesized if K+ diet altered expression of ITSN1 through
miR-194, then, a high K+ diet should reduce expression of
ITSN1. Indeed, high dietary K+ reduced the expression of ITSN1
in the mouse kidney. Based on those results, they examined
whether miR-194 regulated the expression of ITSN1 by using a
wild-type ITSN1-3′UTR, mutant ITSN1-3′UTR, and a luciferase
assay approach. Co-expression (into HEK293T cells) of miR-
194 and ITSN1-3′UTR, but not mutant ITSN1-3′UTR resulted
in altered luciferase activity providing evidence that miR-194
regulated ITSN1. To verify that the effect of miR-194 on
ITSN1 expression was due to ITSN1-3′UTR, the authors used
a flag-tagged ITSN1-3′UTR and 3′UTR-free ITSN1 immunoblot
approach with HEK293T cells. MiR-194 reduced expression of
ITSN1-3′UTR but had no effect on the expression of 3′UTR-free
ITSN1. These data demonstrated that miR194 modulated ITSN1
via the 3′UTR.
He et al. (2007) had previously shown that ITSN1 regulated
the activity of KIR1.1 by up-regulating With-No-Lysine
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(WNK)–induced endocytosis of KIR1.1. Therefore, they
predicted that miR-194 should alter KIR1.1 channel activity
by regulating ITSN1. By using perforated whole cell patch
experiments of HEK293T cells, the authors reported that co-
transfection of KIR1.1 and pre-miR-194 increased the K+ current
compared with control cells only expressing KIR1.1. In order
to determine if miR-194 increased expression of KIR1.1 at the
membrane by modulation of ITSN1, they used biotin-labeling
to determine the surface expression of KIR1.1. Therefore, KIR1.1
expressing HEK293T cells were transfected with pre-miR-194,
pre-miR-194+ ITSN1 or a control oligonucleotide. Immunoblot
results demonstrated that pre-miR-194 enhanced KIR1.1 surface
expression compared to the control nucleotide and that ITSN1
prevented any increase in KIR1.1 surface expression. The authors
concluded that miR-194 increased KIR1.1 channel activity by
enhancing the surface expression of the channel as a result
of miR-194 decreasing ITSN1-WNK-induced endocytosis of
KIR1.1, as demonstrated by co-expression of ITSN1 and miR-
194; which reversed the effect of miR-194 on KIR1.1 surface
expression (Figure 2A).
MiR-205 SUPPRESSES KIR4.1 (KCNJ10) IN
CORNEAL EPITHELIAL CELLS
KIR4.1 is an inwardly rectifying K+ channel cloned from heart,
brain, and skeletal muscle (Bond et al., 1994). KIR4.1 has been
demonstrated in many epithelial tissues including the cornea
(Kofuji et al., 2000; Hamilton and Devor, 2012). KIR4.1 plays
roles in cell adhesion-migration, cell proliferation, and apoptosis
by modulating membrane potential (Chen and Zhao, 2014;
Wang et al., 2014). There is a dearth of information about the
direct evaluation of K+ channels in the healing of differentiated
epithelial cells (Girault and Brochiero, 2014) or the effect of miRs
on the action of KIR4.1.
Lin et al. (2013) provided the first evidence of a miR that
modulated KIR4.1 in the healing process after injury in human
corneal epithelial cells (HCECs). They observed that when a
scratch injury was applied to HCECs, miR-205 expression was
elevated, but miR-16, another expressed miR in HCECs, was not
altered as determined by qRT-PCR. Indeed, they demonstrated
that miR-205 agomir stimulated cell migration in wound closure
of HCECs, while miR-205 antagomir did not. The authors
tested their hypothesis that miR-205 stimulated wound healing
by reducing KIR4.1 by examining the effect of barium, a K+
channel blocker, on HCECs transfected with miR-205 antagomir
in the absence and presence of barium. Cells treated with barium
increased wound recovery compared with cells transfected with
miR-205 antagomir, alone, which had a slower recovery. It
should be noted that barium is a generic K+ channel inhibitor;
nortriptyline has been used to inhibit KIR4.1 in astrocyte cells
(Su et al., 2007). These data suggested that miR-205 altered
KIR4.1 expression. Knockdown of KIR4.1, by siRNA, increased
the growth rate of wound injury suggesting reduced KIR4.1
activity increased cell regrowth.
Since, down regulation of KIR4.1 enhanced cell regrowth,
Lin and coworkers hypothesized that miR-205 may modulate
KIR4.1 in HCECs. In order to test this, they identified a potential
binding region of miR-205 in the 3′UTR of KIR4.1. Therefore,
using their dual luciferase reporter assay (Lin et al., 2011), they
demonstrated that miR-205 decreased KIR4.1 in wild type KIR4.1-
3′UTR in HCECs compared to cells with KIR4.1 and mutant
KIR4.1-3′UTR. Then, the authors reported, with scratch wound
experiments, that the KIR4.1 expression was reduced after 24 h,
while cells transfected with miR-205 antagomir increased the
expression of KIR4.1. This further verified that miR-205 modified
the expression of KIR4.1. Lastly, the authors used the patch-clamp
technique and determined that miR-205-antagomir increased K+
currents while miR-205 agomir reduced K+ currents of HCECs
and that these currents were characteristic of KIR4.1 (Takumi
et al., 1995).
Thus, Lin et al. (2013) suggested that following scratch injury
of HCECs, there was down regulation of KIR4.1 by miR-205
that caused the cells to depolarize more rapidly, which lead
to increased activation of voltage-gated Ca2+ channels (Lin
et al., 2013) increasing the healing process (Figure 2B). However,
it would have been prudent if the authors had conducted
experiments testing the effects of altering the function of voltage-
gated Ca2+ channels while examining the expression of KIR4.1
and miR-205 levels. However, increased intracellular Ca2+ in
HCECs has been suggested to be essential for the release of
growth factors or cytokines to initiate cell proliferation in the
cornea (Du et al., 2006).
MiR-204 INDIRECTLY SUPPRESSES KIR7.1
(KCNJ13) IN RETINAL PIGMENT
EPITHELIUM
KIR7.1 is expressed in retinal pigment epithelium (RPE) and
facilitates interactions between the RPE and photoreceptors
during transitions between light and dark (Wang et al., 2010).
MiR-204 was reported in high amounts in RPE of mice (Bak
et al., 2008). Wang et al. (2010) have provided the first report of
miR-204 in the modulation of KIR7.1 in the RPE.
Initially, Wang et al. (2010) conducted a miRNA expression
profile in native human fetal RPE (hfRPE) by qRT-PCR and
identified that miR-204 was a highly enriched miR. They
further identified miR-204 in fetal RPE culture and native
fetal retina and RPE by Northern blot. Little is known about
the physiological role of miR-204 and coupled with a high
expression of KIR7.1 in the RPE (Yang et al., 2008), Wang
et al. (2010) examined if miR-204 regulated KIR7.1. Therefore,
they conducted semi-quantitative immunoblot experiments in
which they transfected hfRPE with anti-miR-204 or anti-miR-
negative control oligonucleotide and probed for KIR7.1. They
demonstrated that anti-miR-204 reduced the expression of
KIR7.1 compared with control cells, thus suggesting that KIR7.1
is regulated by miR-204. Wang et al. (2010) identified that the
3′UTR of transforming growth factor - beta receptor 2 (TGF-
βR2) was a potential target of miR-204. Using a luciferase
approach, the authors transfected HEK cells with miR-204
mimic and either wt-TGF-βR2-3′-UTR or mutant-TGF-βR2-3′-
UTR. miR-204 mimic reduced the luciferase activity for only
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wt-TGF-βR2-3′-UTR. Further, they confirmed, with an anti-miR-
204 approach as described above, that anti-miR-204 increased
the expression of TGF-βR2 of the hfRPE. From their data, Wang
et al. (2010) proposed that the effect of miR-204 on the increased
expression of KIR7.1 was caused by miR-204’s suppressing action
on TGF-βR2 followed by reduced signaling of protein kinase C
which resulted in increased expression of KIR7.1 as noted by
others (Zhang et al., 2008; Figure 2C).
ROLE OF miR-7 IN REGULATION OF KIR2.1
(KCNJ2) IN SMALL-CELL LUNG CANCER
CELLS (SCLCs)
KIR2.1 is an inward rectifying K+ channel that was described
by Jan and colleagues (Kubo et al., 1993). KIR2.1 maintains the
resting membrane potential in numerous cell types including
SCLCs (Sakai et al., 2002; Hibino et al., 2010). Jirsch et al. (1993)
demonstrated that expression of inwardly rectified K+ channels
was enhanced in the presence of multidrug resistance-associated
protein.
Recently, Liu et al. (2015) provided a link between miR-7
and the upregulation of KIR2.1 in the modulation of multidrug
resistance of SCLCs. They demonstrated that expression of
KIR2.1 was significantly associated with clinical stage and
chemotherapy response in patients with SCLC. Further, they
reported that KIR2.1 expression was more common at serious
disease stage and in drug-resistant patients than in limited disease
stage patients or in drug-sensitive patients. Having demonstrated
a link between KIR2.1 and multidrug resistance, the authors
focused their effort, using immunoblot and Co-IP experiments,
and established that KIR2.1 increased the expression of multi-
drug resistance protein 1 (MRP1) and that these proteins
interacted.
MiR-7 plays an integral part in initiation, proliferation,
invasion, survival, and death by targeting oncogenic signaling
pathways (Gu et al., 2015). Next, Lui and colleagues hypothesized
that the high expression of KIR2.1 might be regulated by
endogenous miR-7. Indeed, they identified, that miR-7 had
a potential interaction site in the 3′UTR of KIR2.1. Using
a luciferase reporter approach, they transfected H69 cells
(human SCLC cell line) with either KIR2.1-3′UTR-wt, KIR2.1-
3′UTR-mutant, or control vector with miR-7 agomir or
antagomir or negative control vector. There was suppressed
luciferase activity when the miR-7 agomir was cotransfected
with KIR2.1-3′UTR-wt, but not when KIR2.1-3′UTR-mutant was
cotransfected with either MiR-7 agomir or antagomir, suggesting
that Kir2.1 is a direct target of miR-7 in SCLCs. The authors
examined the effect of miR-7 on chemoresistance of SCLCs by
analyzing the sensitivity of SCLCs to chemotherapeutic drugs
(adriamycin, cisplatin, and eroposide) after the transfection of
miR-7 agomir, antagomir, or negative control vector. Their
results indicated that upregulation of miR-7 sensitized SCLCs to
all drugs, while downregulation of miR-7 desensitized SCLCs.
These data suggested that miR-7 downregulation may explain
the effects of KIR2.1 on the chemoresistance of SCLCs. Lastly,
the authors confirmed the association between the expression of
KIR2.1 and miR-7 by analyzing the miR-7 expression, by qRT-
PCR, in 52 human SCLC tissue specimens. Correlation data
demonstrated that miR-7 expression was inversely correlated to
KIR2.1 and MRP1 expression. Additionally, low-level expression
of miR-7 was significantly seen with a more aggressive clinical
stage of SCLC. Indeed, SCLC patients with low levels of miR-
7 expression exhibited shorter survival times than patients
with high miR-7 expression. In summary, Liu et al. (2015)
provided a novel method in which KIR2.1 and miR-7 regulate the
sensitivity of SCLC to chemotherapeutic drugs possibly through
the regulation of MRP1 (Figure 2D).
CONCLUSIONS
In this review, we examined the role of miRs in regulating
epithelial K+ channels. While there is little information available,
so far, this is an emerging field of research. The information
gained is important, as epithelial K+ channels play vital roles in
survival and homeostasis.
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